关注
Scott Widenmaier
标题
引用次数
引用次数
年份
Coordinated regulation of protein synthesis and degradation by mTORC1
Y Zhang, J Nicholatos, JR Dreier, SJH Ricoult, SB Widenmaier, ...
Nature 513 (7518), 440-443, 2014
3652014
Glucose‐dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP)
CHS McIntosh, S Widenmaier, SJ Kim
Vitamins & Hormones 80, 409-471, 2009
2312009
NRF1 is an ER membrane sensor that is central to cholesterol homeostasis
SB Widenmaier, NA Snyder, TB Nguyen, A Arduini, GY Lee, AP Arruda, ...
Cell 171 (5), 1094-1109. e15, 2017
1962017
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
A Bartelt, SB Widenmaier, C Schlein, K Johann, RLS Goncalves, K Eguchi, ...
Nature medicine 24 (3), 292-303, 2018
1652018
Glucose-Dependent Insulinotropic Polypeptide-Mediated Up-Regulation of β-Cell Antiapoptotic Bcl-2 Gene Expression Is Coordinated by Cyclic AMP (cAMP …
SJ Kim, C Nian, S Widenmaier, CHS McIntosh
Molecular and cellular biology 28 (5), 1644-1656, 2008
1522008
A GIP receptor agonist exhibits β-cell anti-apoptotic actions in rat models of diabetes resulting in improved β-cell function and glycemic control
SB Widenmaier, SJ Kim, GK Yang, T De Los Reyes, C Nian, A Asadi, ...
PloS one 5 (3), e9590, 2010
1212010
Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the β-cell pro-survival effects of glucose …
SB Widenmaier, Z Ao, SJ Kim, G Warnock, CHS McIntosh
Journal of Biological Chemistry 284 (44), 30372-30382, 2009
1112009
Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells
DS Luciani, SA White, SB Widenmaier, VV Saran, F Taghizadeh, X Hu, ...
Diabetes 62 (1), 170-182, 2013
842013
Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
CHS McIntosh, S Widenmaier, SJ Kim
Journal of diabetes investigation 3 (2), 96-106, 2012
542012
Pleiotropic actions of the incretin hormones
CHS McIntosh, S Widenmaier, SJ Kim
Vitamins & Hormones 84, 21-79, 2010
472010
Pancreatic β-cell prosurvival effects of the incretin hormones involve post-translational modification of Kv2. 1 delayed rectifier channels
SJ Kim, SB Widenmaier, WS Choi, C Nian, Z Ao, G Warnock, ...
Cell Death & Differentiation 19 (2), 333-344, 2012
402012
Noncanonical activation of Akt/protein kinase B in β-cells by the incretin hormone glucose-dependent insulinotropic polypeptide
SB Widenmaier, AV Sampaio, TM Underhill, CHS McIntosh
Journal of biological chemistry 284 (16), 10764-10773, 2009
402009
Only iron-limited cells of the cyanobacterium Anabaena flos-aquae inhibit growth of the green alga Chlamydomonas reinhardtii
CJ Matz, MR Christensen, AD Bone, CD Gress, SB Widenmaier, ...
Canadian journal of botany 82 (4), 436-442, 2004
222004
Proteostasis in thermogenesis and obesity
A Bartelt, SB Widenmaier
Biological Chemistry 401 (9), 1019-1030, 2020
192020
Complementary gene regulation by NRF1 and NRF2 protects against hepatic cholesterol overload
MG Akl, L Li, R Baccetto, S Phanse, Q Zhang, MJ Trites, S McDonald, ...
Cell reports 42 (4), 2023
112023
Immune cell intolerance for excess cholesterol
SB Widenmaier, GS Hotamışlıgil
Immunity 45 (6), 1186-1188, 2016
62016
HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2
MJ Trites, BM Stebbings, H Aoki, S Phanse, MG Akl, L Li, M Babu, ...
Frontiers in Physiology 14, 1212785, 2023
42023
Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
MG Akl, SB Widenmaier
Frontiers in Cell and Developmental Biology 10, 1089124, 2023
32023
Euglycemia is affected by stress defense factor hepatocyte NRF1, but not NRF2
MG Akl, R Baccetto, BM Stebbings, L Li, SB Widenmaier
Biochemical and Biophysical Research Communications 668, 96-103, 2023
22023
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders
GS Hotamisligil, MF Burak, F Engin, SB Widenmaier, EH Roberts, ...
US Patent 11,014,979, 2021
22021
系统目前无法执行此操作,请稍后再试。
文章 1–20